RNA Delivery Function for Anticancer Therapeutics

The book discusses the translation of RNAi cancer therapeutics in the clinic, biological barriers in drug delivery, and the roles of imaging in preclinical development. It highlights the importance of imaging methods in facilitating the development and delivery of RNAi therapeutics, which have the potential to treat genetic disorders such as cancer.

Format: Hardback
Length: 404 pages
Publication date: 26 January 2022
Publisher: Taylor & Francis Ltd

This comprehensive book delves into the realm of translating RNAi cancer therapeutics into clinical practice, offering a comprehensive overview of the current status, biological barriers, and imaging-guided delivery strategies. It begins by providing a broad perspective on the translation journey, encompassing the biological barriers that hinder drug delivery and the crucial roles of imaging in optimizing administration routes, systemic circulation, and cellular barriers. Additionally, the book explores the safety concerns associated with RNAi cancer therapeutics.

The book then focuses on imaging-guided delivery of RNAi therapeutics in preclinical development, encompassing the fundamental principles of various imaging modalities and their advantages and limitations for biological imaging. With the increasing number of RNAi therapeutics entering clinical trials, the importance of imaging methods in facilitating the translation of RNAi cancer therapeutics from bench to bedside becomes increasingly evident.

RNAi technology, which involves the targeted silencing of genes, has revolutionized basic research by enabling the selective knockdown of gene expression in vitro and in vivo. The scientific and industrial communities have embraced RNAi therapeutics as the next generation of drugs for treating a wide range of genetic disorders, including cancer, which poses significant challenges to conventional treatment approaches.

This book serves as a valuable resource for researchers, clinicians, and pharmaceutical professionals seeking to advance RNAi cancer therapeutics. It provides insights into the latest advancements, challenges, and opportunities in this field, enabling readers to stay informed about the latest developments and contribute to the translation of RNAi cancer therapeutics into clinical practice.

Weight: 943g
Dimension: 280 x 210 (mm)
ISBN-13: 9781032135168